Cargando…

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis

Acute kidney injury (AKI) is a prevalent pathological condition that is characterized by a precipitous decline in renal function. In recent years, a growing body of studies have demonstrated that renal maladaptation following AKI results in chronic kidney disease (CKD). Therefore, targeting the tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Runzhi, Duan, Jiayu, Pan, Shaokang, Cheng, Fei, Qiao, Yingjin, Feng, Qi, Liu, Dongwei, Liu, Zhangsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344918/ https://www.ncbi.nlm.nih.gov/pubmed/37443140 http://dx.doi.org/10.1038/s41419-023-05969-9

Ejemplares similares

Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials
por: Feng, Qi, et al.
Publicado: (2022)

Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities
por: Wang, Hui, et al.
Publicado: (2023)

Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases
por: Feng, Qi, et al.
Publicado: (2023)

Ferroptosis: A new insight for treatment of acute kidney injury
por: Li, Shiyang, et al.
Publicado: (2022)

Diabetes Mellitus as a Risk Factor for Progression from Acute Kidney Injury to Acute Kidney Disease: A Specific Prediction Model
por: Zhao, Huanhuan, et al.
Publicado: (2021)

A Comprehensive Weighted Gene Co-expression Network Analysis Uncovers Potential Targets in Diabetic Kidney Disease
por: Pan, Shaokang, et al.
Publicado: (2023)

Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey
por: Duan, Jiayu, et al.
Publicado: (2019)

Broadening horizons: the contribution of mitochondria-associated endoplasmic reticulum membrane (MAM) dysfunction in diabetic kidney disease
por: Liu, Yong, et al.
Publicado: (2023)

Integrative Analysis of m(6)A Regulator-Mediated RNA Methylation Modification Patterns and Immune Characteristics in Lupus Nephritis
por: Zhao, Huanhuan, et al.
Publicado: (2021)

Stem cells: a potential treatment option for kidney diseases
por: Liu, Dongwei, et al.
Publicado: (2020)

REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells
por: Gong, Shuiqin, et al.
Publicado: (2023)

Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy
por: Yan, Qianqian, et al.
Publicado: (2022)

Infectious consequences of the AKI-to-CKD transition
por: Sánchez Horrillo, Ana, et al.
Publicado: (2022)

Concise review: current trends on applications of stem cells in diabetic nephropathy
por: Liu, Dongwei, et al.
Publicado: (2020)

HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression
por: Zhang, Lijun, et al.
Publicado: (2023)

From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
por: Wang, Zhiwen, et al.
Publicado: (2022)

Relationship between serum iPTH and peritonitis episodes in patients undergoing continuous ambulatory peritoneal dialysis
por: Zhao, Zihao, et al.
Publicado: (2023)

Corrigendum: Relationship between serum iPTH and peritonitis episodes in patients undergoing continuous ambulatory peritoneal dialysis
por: Zhao, Zihao, et al.
Publicado: (2023)

Dynamic signature of lymphangiogenesis during AKI and CKD
por: Zarjou, Abolfazl, et al.
Publicado: (2019)

The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence
por: Chen, Jia-Huang, et al.
Publicado: (2021)

NLRP3-mediated pyroptosis in diabetic nephropathy
por: Wan, Jiayi, et al.
Publicado: (2022)

Meta-analysis of AKI to CKD transition in perioperative patients
por: M. Abdala, Pedro, et al.
Publicado: (2021)

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

EGFR drives the progression of AKI to CKD through HIPK2 overexpression
por: Xu, Luyang, et al.
Publicado: (2019)

Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions
por: Huo, Jin-Ling, et al.
Publicado: (2023)

Metabolic Understanding of the Genetic Dysregulation in the Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma
por: Xie, Junwei, et al.
Publicado: (2022)

The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation
por: Kant, Sam, et al.
Publicado: (2020)

IL-18 deficiency ameliorates the progression from AKI to CKD
por: Luan, Junjun, et al.
Publicado: (2022)

VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis
por: Hu, Zhaoxin, et al.
Publicado: (2020)

Determining the influence of high glucose on exosomal lncRNAs, mRNAs, circRNAs and miRNAs derived from human renal tubular epithelial cells
por: Zhou, Sijie, et al.
Publicado: (2021)

Lysine Acetylation in the Proteome of Renal Tubular Epithelial Cells in Diabetic Nephropathy
por: Wan, Jiayi, et al.
Publicado: (2021)

Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagy
por: Yu, Qi, et al.
Publicado: (2019)

RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018)

AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease
por: Lee, Kyung, et al.
Publicado: (2022)

The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD
por: Kim, Dong-Hyun, et al.
Publicado: (2021)

Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients
por: Ren, Jingjing, et al.
Publicado: (2022)

Glycogen synthase kinase-3β is required for epithelial-mesenchymal transition and barrier dysfunction in mouse podocytes under high glucose conditions
por: Guo, Jia, et al.
Publicado: (2016)

Glycogen synthase kinase-3β is required for epithelial-mesenchymal transition and barrier dysfunction in mouse podocytes under high glucose conditions
por: Guo, Jia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_inc0l33gfeddmn0jrkqglc1qju